526 Removal of soluble tumor necrosis factors receptors 1/2 in patients with metastatic solid tumors using immune apheresis

• Ronnie Shapira-Frommer,
• Robert Segal,
• Gal Markel,
• Nethanel Asher,
• Ayala Tamir,
• Hagit Harati,
• Ronen Stoff,
• Shirly Grynberg,
• Adam Ostrowski,
• Lawrence Florin

Affiliations

Ronnie Shapira-Frommer

Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center at Tel Hashomer, Tel Hashomer, Israel

Robert Segal

3Immunicom Inc., San Diego, CA, USA

Gal Markel

Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center at Tel Hashomer, Tel Hashomer, Israel

Nethanel Asher

Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center at Tel Hashomer, Tel Hashomer, Israel

Ayala Tamir

1Sheba Medical Center, Israel, Ramat Gan, Israel

Hagit Harati

2Sheba Medical Center, Ramat Gan, Israel

Ronen Stoff

2Sheba Medical Center, Ramat Gan, Israel

Shirly Grynberg

2Sheba Medical Center, Ramat Gan, Israel

Adam Ostrowski

3Immunicom Inc., San Diego, CA, USA

Lawrence Florin

3Immunicom Inc., San Diego, CA, USA